147 related articles for article (PubMed ID: 18481268)
1. Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.
Zhang J; Wilkinson JE; Gonit M; Keck R; Selman S; Ratnam M
Prostate; 2008 Aug; 68(11):1206-14. PubMed ID: 18481268
[TBL] [Abstract][Full Text] [Related]
2. C/EBPalpha redirects androgen receptor signaling through a unique bimodal interaction.
Zhang J; Gonit M; Salazar MD; Shatnawi A; Shemshedini L; Trumbly R; Ratnam M
Oncogene; 2010 Feb; 29(5):723-38. PubMed ID: 19901962
[TBL] [Abstract][Full Text] [Related]
3. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.
Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K
Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820
[TBL] [Abstract][Full Text] [Related]
4. Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line.
Yin H; Radomska HS; Tenen DG; Glass J
BMC Cancer; 2006 Jun; 6():158. PubMed ID: 16774685
[TBL] [Abstract][Full Text] [Related]
5. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
Yin H; Lowery M; Glass J
Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
[TBL] [Abstract][Full Text] [Related]
6. Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.
Yin H; Smith M; Glass J
Prostate; 2005 Feb; 62(3):209-16. PubMed ID: 15389791
[TBL] [Abstract][Full Text] [Related]
7. Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein alpha.
Yang J; Croniger CM; Lekstrom-Himes J; Zhang P; Fenyus M; Tenen DG; Darlington GJ; Hanson RW
J Biol Chem; 2005 Nov; 280(46):38689-99. PubMed ID: 16166091
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma.
Pan Z; Zheng W; Zhang J; Gao R; Li D; Guo X; Han H; Li F; Qu S; Shao R
BMC Cancer; 2014 Jun; 14():417. PubMed ID: 24913332
[TBL] [Abstract][Full Text] [Related]
9. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
10. C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades.
Shi YC; Zhao H; Yin C; Zeng X; Zhang Q; Xu WP; Wei J; Chen F; Xie WF
Dig Liver Dis; 2013 Oct; 45(10):844-51. PubMed ID: 23816696
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.
Sato A; Yamada N; Ogawa Y; Ikegami M
PLoS One; 2013; 8(2):e57013. PubMed ID: 23437297
[TBL] [Abstract][Full Text] [Related]
13. In prostate cancer cells the interaction of C/EBPalpha with Ku70, Ku80, and poly(ADP-ribose) polymerase-1 increases sensitivity to DNA damage.
Yin H; Glass J
J Biol Chem; 2006 Apr; 281(17):11496-505. PubMed ID: 16490787
[TBL] [Abstract][Full Text] [Related]
14. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.
Yong KJ; Basseres DS; Welner RS; Zhang WC; Yang H; Yan B; Alberich-Jorda M; Zhang J; de Figueiredo-Pontes LL; Battelli C; Hetherington CJ; Ye M; Zhang H; Maroni G; O'Brien K; Magli MC; Borczuk AC; Varticovski L; Kocher O; Zhang P; Moon YC; Sydorenko N; Cao L; Davis TW; Thakkar BM; Soo RA; Iwama A; Lim B; Halmos B; Neuberg D; Tenen DG; Levantini E
Sci Transl Med; 2016 Aug; 8(350):350ra104. PubMed ID: 27488898
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
Xue M; Li X; Chen W
Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
[TBL] [Abstract][Full Text] [Related]
16. Expression of the cancer-testis antigen BORIS correlates with prostate cancer.
Cheema Z; Hari-Gupta Y; Kita GX; Farrar D; Seddon I; Corr J; Klenova E
Prostate; 2014 Feb; 74(2):164-76. PubMed ID: 24123052
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells.
Kumagai T; Akagi T; Desmond JC; Kawamata N; Gery S; Imai Y; Song JH; Gui D; Said J; Koeffler HP
Int J Cancer; 2009 Feb; 124(4):827-33. PubMed ID: 19035457
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of fatty acid translocase/CD36 expression by CCAAT/enhancer-binding protein alpha.
Qiao L; Zou C; Shao P; Schaack J; Johnson PF; Shao J
J Biol Chem; 2008 Apr; 283(14):8788-95. PubMed ID: 18263877
[TBL] [Abstract][Full Text] [Related]
20. C/EBPα Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting β-Catenin.
Lu J; Du C; Yao J; Wu B; Duan Y; Zhou L; Xu D; Zhou F; Gu L; Zhou H; Sun Y
Cell Physiol Biochem; 2017; 42(5):1779-1788. PubMed ID: 28746919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
